chrisvoncsefalvay/vaers-outcomes huggingface dataset:
February of 2022 I got diagnosed with a cancerous brain tumor. Resection on Fb 10th. Chemo and radiation around going to start March 21, 2022.
Information unavailable.  Medical records not received from LTC facility.  Death certificate lists Covid 19 as cause of death.
pain; swelling of right arm; a round lump the size of a "50 cent piece"/where she got the shot she has a lump; dizziness; This is a spontaneous report from a contactable consumer reporting for herself. A 58-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 12Aug2021 as single dose for covid-19 immunization. Medical history included, diabetes mellitus, and Crohn's disease from an unknown date and unknown if ongoing. The patient previously received first dose of bnt162b2 (Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on unknown date as single dose for covid-19 immunization and experienced dizzy. The patient concomitant medications were not reported. On unknown date in Aug2021, the patient experienced pain, swelling of right arm, and a round lump the size of a "50 cent piece" and dizziness. It was reported that, she got the second Pfizer shot yesterday morning and she woke up this morning, and where she got the shot, she has a lump. She was calling about the covid vaccine. She was asking if it was normal. She has a side effect sheet and does not see it. The first shot she got was fine, she had no pain, nothing. Yesterday when she got the second shot, she did experience dizziness. She did get dizzy with the first shot and it passed in one or two hours and was not concerned about that part. She got her second shot in her right arm and her right arm was swollen and she has a lump, it was not a big lump. She was diabetic and has Crohn's disease and she was not sure if that has anything to do with it. She got the shots through her doctor and that has been her doctor for seven years. The outcome of the event pain resolved on unknown date in Aug2021, while the outcome of other events was unknown.    The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
She said she continues to have soreness from the flu shot.  She said it was sore after the shot a "normal" amount then she thinks it got better for a time when she didn't notice any pain but then it got worse.  She tried Ice/Heat/Massage/Exercise with no relief.  Ibuprofen does help the pain.  She said it is not tender/no redness.  She has full range of motion but certain motions such as cross body pulling send a sharp pain and she thinks she has lost some strength.  She will likely try to see MD to evaluate further.
Patient was given 0.5 ml FLUZONE in left deltoid, 24 hours later swelling, redness, itchiness around injection site.
Shingles; This is a spontaneous report from a contactable consumer (patient). A 75-year-old male patient received the first dose of BNT162B2, via an unspecified route of administration on 02Feb2021 14:30 at single dose in Right arm for COVID-19 immunisation. Medical history included known allergies: Duck eggs, rheumatoid arthritis (RA), type 2 diabetes, all from an unknown date. Concomitant medications included RA injections. There was no other vaccine in four weeks. The patient did not have COVID prior vaccination. The patient experienced shingles on 08Feb2021. Covid was not tested post vaccination.  Therapeutic measures were taken as a result of shingles which included unspecified medication. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. The outcome of event was recovering.  Information about lot/batch number has been requested.
Vaccines administered in supine position due to history of syncope with blood draws. 15 min post injection, patient assisted to sit, then stand. Became lightheaded and assisted to lying position. Loss of consciousness, eyes rolled back in head, limbs became stiff. Unresponsive x 1 min. After 1 min, became responsive and oriented. Hypotension and bradycardia noted. Observed x 30 minutes. BP 90/50. HR 80; discharged to mother's care 30 min. after episode.
Janssen (J&J) COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Janssen (J&J) Vaccine on 7/3/2021. Patient was diagnosed with COVID on 9/29/2021 and reportedly received Regeneron monoclonal antibody treatment. Patient presented to emergency department with hypoxia on 10/2/2021. Patient immediately required supplemental oxygen. Throughout hospitalization, patient's oxygen requirements increased and patient decompensated. Patient received: dexamethasone and azithromycin. Patient was transitioned to comfort care and expired 10/11/2021 at 0225.
Information has been received from a registered nurse concerning a male patient who on 11-AUG-2010 was vaccinated with a 0.5ml dose of VARIVAX (Merck) (lot# 666694/1710Y). Mother of child reported that on 14-OCT-2010 the patient developed a rash on his upper body and had a fever. No medical attention was sought. The patient's rash on his upper body and a fever persisted. Additional information has been requested.
Chills, Body Aches, Headache, dizziness, nausea (upon standing) and high Fever (103 degrees).  Treated as flu; drank plenty of fluids, too ibuprofen for the pain & fever and slept alot.  Monday, 12/5/11, had to stay home from work because I still had headache and body aches with a low grade fever (slighty above 100 degrees).  Tuesday, 12/6/11, sneezing and runny nose.
09/23 starting at 10:30 pm (approx 8 h after vaccination): fever up to 102 deg F, chills, sweats, extreme fatigue, lethargy, all resolved approximately 36 h later 09/24 starting at 2:30 am (approx 12 h after vaccination): nausea and vomiting within 12 h of receiving vaccine, resolved within 12 h of onset 10/12 approx 3 weeks after vaccination - onset of symptoms of EGPA vasculitis flare (petechiae on arm, peripheral neuropathy, sinonasal symptoms, eye discharge)
Patient placed a call stated she took her first dose of the oral typhoid vaccine yesterday morning around 7:30 AM. Patient stated that later in the afternoon around 4:00 PM yesterday she experienced "excruciating pain and tingling from the waist down". Patient stated the pain was so awful that she almost went to the ER. Patient stated that on 9/03/14 she feels "muscle soreness" from the waist down. Patient stated she did not have any other side effects. Patient denied fever, vomiting, diarrhea, stomach pain, headache, SOB or rashes. Patient stated that she took ibuprofen and her muscle pain and tingling subsided.
Patient indicated at 27 weeks and 2 days. Patient indicated they had redness at injection site. Swelling, fever of 100.4, soreness and significant rash. Tested positive for flu in addition to rash and swelling o f left arm
Rushed to ER. Has now been tubed and put into the ICU and has had full-cardiac arrest less than 24 hours after receiving the vaccine.
On 1/21/22 patient is a 15 year old came into the office for a COVID vaccine, scheduled incorrectly and administered Moderna COVID Vaccine. Error recognized on 1/31/22, parent notified by PCP. Reviewed CDC recommendations and patient scheduled to return to office for Pfizer vaccine on 2/18/22 (28 days after first dose).
2 inch x 3 1/2 inch oval rash at vaccine site. Red, warm, hardened, itchy. Resolved in 3 days.
Got YF shot on the 26th. About pm of 5/30 patient had a rash on YF site. Patient was larger (about 6" width). But didn't hurt. Patient had an ADACEL shot on that arm 5/19.
flu-like symptoms after first dose vaccination.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as 1st dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "flu-like symptoms after first dose vaccination." No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This is a spontaneous report from a Pfizer-sponsored program. A contactable Clinical Service Manager reporting on behalf of pharmacist that a patient of an unspecified age, gender and ethnicity received PREVNAR 13 for immunization at single dose on unknown date. Medical history and concomitant medication were unknown. The patient experienced sore arm after receiving the vaccine. The outcome of the event was unknown.
Facial numbness bilaterally with headache 3 hours post injection. 15 hrs post injection: 101 temperature, severe chills and joint pain (making it difficult to walk), body aches and extreme fatigue. Headache continued but facial numbness subsided. Symptoms less severe at 48hrs, low grade temp and body aches persisted, joint pain resolved. All symptoms resolved at 72 hrs.
3/26/21 recipient received the 1st dose of the Moderna vaccine.  On 4/22/2021 recipient received Pfizer for his 2nd dose.  CDC notified with no recommendations.
Mother called our office on 9/30/16 stating that patient was having facial/neck swelling. They were sent to the ER.
Its 31 days after my 2nd dose & I got my period. I'm 51 & I have an IUD, I haven't had a period in over 2 years. I had 7 days of moderate to severe PMS symptoms including cramps, back pain and breast tenderness-I havent had those types of PMS issues since my 20's.  Not a terrible side effect, but weird.
received her two doses / 28 days apart, 08Dec2020 and 05Jan2021; myalgia 3 days after the 2nd dose.; This case was reported by a pharmacist and described the occurrence of myalgia in a 83-year-old female patient who received Herpes zoster (Shingrix) (batch number 3PD3E, expiry date 8th October 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 5th January 2021, the patient received the 2nd dose of Shingrix. On 5th January 2021, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. In January 2021, the patient experienced myalgia. On an unknown date, the outcome of the myalgia was not recovered/not resolved and the outcome of the drug dose administration interval too short was unknown.   It was unknown if the reporter considered the myalgia to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. 3 days after receiving 2nd dose of Shingrix, patient experienced myalgia. The patient received 2nd dose of Shingrix, less than the recommended interval , which led to shortening of vaccination schedule. The reporter did not consent to follow up.
Initial unsolicited report received from a nurse on 14 December 2015. This case involves a 11-year-old male patient who was vaccinated with a intramuscular dose of MENACTRA (batch number U5179AA, expiry date and site of administration were not reported) and also received dose BOOSTRIX (manufacturer GSK, batch number 2729X, expiry date and site of administration were not reported), received a dose of Hep A (manufacturer other, batch number F3J75, expiry date and site of administration were not reported) and also received a dose of HPV (manufacturer other, batch number L014415, expiry date and site of administration were not reported) all vaccine administered on 11 December 2015. Illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions was reported as none. Concomitant medications were not reported. On 11 December 2015, within seconds after vaccination patient passed out. Patient had no laboratory investigation. Corrective treatment was not reported. The outcome of event was recovered (passed out for 5 seconds). Upon internal review, the company decided to consider the event serious because of the important medical event passed out. List of documents held by sender: none.
Hospitalized with MIS C. 2/21  fever for approximately one week along with rash, cracked lips, periorbital edema 2/22 no improvement so hospitalized given with marked improvement.
This spontaneous report was received from a medical assistant concerning a 5 year old child patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. On an unknown date in January 2018, the patient was vaccinated with improperly stored PROQUAD, lot # N019248 and expiration date 20-DEC-2018, (strength, dose, frequency and route of administration were not reported) for prophylaxis. No adverse symptoms were reported. The temperature of excursion was reported as - 6.3 Celsius degrees during a time frame of 1 hour and 26 minutes on 02-JAN-2018. There was no previous temperature of excursion reported. There was a digital data logger involved. This is one among the several reports reported by the medical assistant. Sender's Comments: US-009507513-1801USA002808: US-009507513-1806USA010177: US-009507513-1806USA010171: US-009507513-1806USA010179: US-009507513-1806USA010180: US-009507513-1806USA010176: US-009507513-1806USA010181: US-009507513-1806USA010174: US-009507513-1806USA010173: US-009507513-1806USA010175:
Supportive therapy Aveeno bath, Caladryl lotion, Benadryl
Started with very sore arm evening of shot. Next day  - queasy stomach, headache, all over achiness, continued sore arm but better than prior pm. Arm still a little sore following day but all other symptoms gone.
Patient was inadvertently given the vaccine at age 11 years. Mother was notified and was aware of age. She voiced that she wanted child to get the second dose. Writer explained that we could not do that until after the 12th birthday.
Fever and chills starting about 24 hours after receiving the vaccine, lasted about 12 hours
Administered expired vaccine to patient after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine to patient after the manufacture date of expiration) in a 53-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine to patient after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine to patient after the manufacture date of expiration) outcome was unknown.     For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 173 doses.  The vial did not undergo any temperature excursions.  Treatment information was not provided.   This case was linked to MOD-2022-581986 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live follow up received included non significant information of secondary reporter was added.
Hospitalized 11/20/2021; COVID-19 positive 11/16/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider:  Primary Care Provider:  Admission Date: 11/20/2021 Discharge Date: Nov 24, 2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] COVID [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 70 y.o. male with past medical history significant for T2DM, CKD3, BPH, HTN and HLD who presented to the ED with a cough. Patient was found to have mild respiratory failure and sating well on 2L supplemental O2. COVID19 positive and started on decadron. Remdesivir was held for increased in creatinine. He was also found to have elevated glucose levels for which he was started on an insulin qtt and admitted to the hospital. Pt.'s sugars have done well over night and his SOB has improved, but still remained stable on 1L O2 at rest for several days prior to discharge. Patient required 3-6L O2 with ambulation. Pulm rehab was consulted and arranged for home O2. DGMS was consulted and adjusted insulin. Patient is comfortable with insulin at home as he wife previously used it as well and can assist. He was discharged on 5 days of decadron and was given instructions for how to adjust insulin once steroids are complete.
My left arm hurts and I have a small bamp on my clavicle bone, and it hurst under my armpit and is a       little puffy. This happended after the COVID19 Moderna vaccine.
Achy pain left brachial arm. (vaccine given in right deltoid).  A week later began to have numbness and tingling in left arm progressing to left leg and then to right arm and leg.  Also sharp shooting nerve pains.  Had brain and cervical spine to r/o any other cause of symptoms.  Has progressively improved but I still have buzzing around feet and ankles and sporadic shooting nerve pain in arms and legs.
Headache, Sedation, Myalgia, Arthralgia, Fever, Chills, pain and redness at the injection site Narrative:
Patient called me on 9/8/19 at 10 am and let me know that around 10 pm on 9/7/19 he started to experience fits of hiccuping followed by vomiting. This continued throughout the night until around 8 am the next morning. When he and I spoke at 10 am he was still feeling nauseous but was no longer hiccuping or throwing up.
Maculo papular rash across back and upper arms. Feeling chest pain/pressure. Rx: Antihistamine and Zantac. Had similar Sx after a previous anthrax vaccine.
Patient was vaccinated at 9:55 am with 0.3mL of Moderna bivalent vaccine instead of 0.5mL. Patient was contacted via phone at 1148 and reported no adverse effects. Patient agreed to come in again to get revaccinated per medical officer. Patient came in at 1210 and received 0.5mL Moderna Bivalent per CDC guidelines for dosing errors and stayed for 15 minutes with no issues.
Pfizer booster after 2 Moderna shots (which may have had a similar side effect but on chest)...itchy rash on forearms, 3 patches on upper left forearm, 1+ on right...ongoing...treating with water, coconut oil, and sometimes turmeric topically applied...pending appointment with dermatologist (chest patches less severe itch,belatedly attributed to the Moderna shots,  treated only with moisture)
Side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Side effects). At the time of the report, ADVERSE EVENT (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications reported. no treatment details reported.
LESS THAN 48 HOURS AFTER BEING VACCINATED, I STARTED BLEEDING. IT STARTED LIKE A PERIOD THAT SUDENLY TURNED INTO MENORRAGHIA. THE FIRST 4 DAYS CONSISTED OF HEAVY BLEEDING ALONG WITH LOTS OF CLOTS AND CRAMPING. I EXPERIENCED LEG WEAKNESS AND BACK ACHE. I HAD A LOW GRADE FEVER AT NIGHT TIME AND CHILLS. THE BLEEDING CONTINUED FROM HEAVY TO LIGHT FOR ABOUT 10 DAYS OR SO. I WAS WORRIED BECAUSE I HAD ACTUALLY STOPPED MENSTRUATING 8 MONTHS BEFORE. BEFORE THE VACCINE SHOT, I HAD NEVER EXPERIENCED ANYTHING LIKE THIS. IT WAS SUDDEN AND MY BODY GAVE ME NO WARNINGS. I HAVE NOT HAD ANY BLEDDING OR  A "PERIOD" SINCE THIS HAPPENED. I WILL NOT BE GOING BACK  FOR A SECOND DOSE BECAUSE OF MY BODY'S REACTION. I AM SCHEDULED TO SEE MY OB/GYN FOR MY ANNUAL CHECK UP SOON.
A non-serious report of administration of expired FLUMIST was received from an Air Force non-commissioned officer and a health care professional concerning a 21-year-old male.  The patient's medical history and concomitant medications were not reported.  On 06-Oct-2008, the patient was given FLUMIST via nasal administration by an immunization health technician.  The vaccine was found to be expired when a nurse in the same clinic noted that the lot# of the administered FLUMIST (expiration date 24-Mar-2008) was different from the lot# of the other supply of FLUMIST with expiration date of 25-Dec-2008.  The expired lot of FLUMIST was given to 17 adult individuals including this patient.  The reporter stated that prior to being informed by the immunization clinic, the expired lot of FLUMIST was already suspended for use by their office and that suspended lot is collected by a contracted company for disposal.  There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.  Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired.  Follow-up information was received on 09-Apr-2009:  Product Complaint Investigation results.
Patient vomited 5 minutes after receiving his 2nd dose of the Pfizer Covid vaccine.
Rash covering full body and face. Did not bother him too much but he was covered. 5 days.
Received 0.5 Ml Moderna booster instead of 0.25 ml.  Day of no symptoms.  24 hours later nausea, low fever, intermittent achiness, and headache.  Tired continues may be related life stress.
Case number PHEH2015US024820, is an initial spontaneous report received from a health care professional on 23 Nov 2015. This report refers to a 57-year-old female patient. Medical history was not reported. Concomitant medication was not reported. Vaccination history included administration of FLUVIRIN in the past and it was well tolerated. The patient was vaccinated with FLUVIRIN (batch number: 1515701) multi dose vial (MDV) intramuscularly in the left deltoid at a dose of 0.5 ml on 23 Nov 2015 at 08.48 a.m. It was reported that the vaccine administered was out of temperature range at 46.8 degree Fahrenheit for 24 hours. The case was reported as non-serious. No adverse events were reported following the maladministration. Follow up information received from a health care professional on 21 Jan 2015: Vaccination history, batch number and site of vaccination.
Patient received a expired vaccine 16 Apr 2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a expired vaccine 16 Apr 2022) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007J21-2a) for COVID-19 vaccination.     The patient did not have any allergies No other vaccine was given prior to Moderna Covid-19 Vaccine.     On 22-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a expired vaccine 16 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a expired vaccine 16 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that patient had never had COVID positive test nor diagnosis.  No concomitant medication were reported.  No treatment medication were reported.